Preneoplastic conditions in the stomach: Always a point of no return?

Digestive Diseases

Volumn 33, Issue 1, 2014, Pages 5-10

  Venerito, Marino ^a   Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Gastric atrophy; Gastric cancer; Helicobacter pylori; Intestinal metaplasia

Indexed keywords

CANCER INCIDENCE; CANCER PREVENTION; DISEASE CLEARANCE; ENDOSCOPIC SURGERY; GASTRITIS; HELICOBACTER INFECTION; HIGH RISK POPULATION; HISTOLOGY; HUMAN; INTESTINE METAPLASIA; PRECANCER; REVIEW; SEROLOGY; STOMACH ATROPHY; STOMACH CANCER; STOMACH MUCOSA; DISEASE ERADICATION; HELICOBACTER PYLORI; MICROBIOLOGY; NEOPLASMS, SECOND PRIMARY; PATHOLOGY; PHYSIOLOGY; STOMACH; STOMACH NEOPLASMS;

DISEASE ERADICATION; HELICOBACTER PYLORI; HUMANS; NEOPLASMS, SECOND PRIMARY; PRECANCEROUS CONDITIONS; STOMACH; STOMACH NEOPLASMS;

EID: 84919832969     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000369185     Document Type: Review

References (35)

1. Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et al: Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16: 1249-1259.
2. Dixon MF, Genta RM, Yardley JH, Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-1181.
3. Kuipers EJ, Uyterlinde AM, Peña AS, Roosendaal R, Pals G, Nelis GF, et al: Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-1528.
4. Kuipers EJ: Review article: Relationship between Helicobacter pylori , atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 1998; 12: 125-136.
5. Wolf EM, Plieschnegger W, Geppert M, Wigginghaus B, Höss GM, Eherer A, Schneider NI, Hauer A, Rehak P, Vieth M, Langner C: Changing prevalence patterns in endoscopic and histological diagnosis of gastritis? Data from a cross-sectional Central European multicentre study. Dig Liver Dis 2014; 46: 412-418.
6. Samloff IM, Taggart RT: Pepsinogens, pepsins, and peptic ulcer. Clin Invest Med 1987; 10: 215-221.
7. Borch K, Axelsson CK, Halgreen H, Damkjaer Nielsen MD, Ledin T, Szesci PB: The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol 1989; 24: 870-876.
8. Kekki M, Samloff IM, Varis K, Ihamäki T: Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol 1991; 186: 109-16.
9. Varis K, Sipponen P, Laxen F, Samloff IM, Huttunen JK, Taylor PR; Helsinki Gastritis Study Group: Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand J Gastroenterol 2000; 35: 950-956.
10. Dinis-Ribeiro M, Areia M, de Vries AC, et al; European Society of Gastrointestinal Endoscopy; European Helicobacter Study Group; European Society of Pathology; Sociedade Portuguesa de Endoscopia Digestiva: Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44: 74-94.
11. Satoh K: Does eradication of Helicobacter pylori reverse atrophic gastritis or intestinal metaplasia? Data from Japan. Gastroenterol Clin North Am 2000; 29: 829-835.
12. http://en.wiktionary.org/wiki/point-of-no- return. Research entered on October 9th, 2014.
13. Varis K, Sipponen P, Laxen F, Samloff IM, Huttunen JK, Taylor PR; Helsinki Gastritis Study Group: Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand J Gastroenterol 2000; 35: 950-956.
14. Shikata K, Kiyohara Y, Kubo M, Yonemoto K, Ninomiya T, Shirota T, Tanizaki Y, Doi Y, Tanaka K, Oishi Y, Matsumoto T, Iida M: A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study. Int J Cancer 2006; 119: 196-201.
15. Hishida A, Matsuo K, Goto Y, Naito M, Wakai K, Tajima K, Hamajima N: Smoking behavior and risk of Helicobacter pylori infection, gastric atrophy and gastric cancer in Japanese. Asian Pac J Cancer Prev 2010; 11: 669-673.
16. Yokoyama A, Omori T, Yokoyama T, Kawakubo H, Mori S, Matsui T, Maruyama K: Chronic atrophic gastritis and metachronous gastric cancer in Japanese alcoholic men with esophageal squamous cell carcinoma. Alcohol Clin Exp Res 2009; 33: 898-905.
17. Yoshida T, Kato J, Inoue I, Yoshimura N, Deguchi H, Mukoubayashi C, Oka M, Watanabe M, Enomoto S, Niwa T, Maekita T, Iguchi M, Tamai H, Utsunomiya H, Yamamichi N, Fujishiro M, Iwane M, Takeshita T, Ushijima T, Ichinose M: Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer 2014; 134: 1445-1457.
18. Vannella L, Lahner E, Osborn J, Annibale B: Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther 2013; 37: 375-382.
19. Saghier AA, Kabanja JH, Afreen S, Sagar M: Gastric Cancer: environmental risk factors, treatment and prevention. J Carcinog Mutagen 2013;S14: 008.
20. Pritchard DM, Crabtree JE: Helicobacter pylori and gastric cancer. Curr Opin Gastroenterol 2006; 22: 620-625.
21. Takaishi S, Okumura T, Wang TC: Gastric cancer stem cells. J Clin Oncol 2008; 26: 2876-2882.
22. Kakinoki R, Kushima R, Matsubara A, Saito Y, Okabe H, Fujiyama Y, et al: Re-evaluation of histogenesis of gastric carcinomas: a comparative histopathological study between Helicobacter pylori -negative and H. pylori -positive cases. Dig Dis Sci 2009; 54: 614-620.
23. Mesquita P, Raquel A, Nuno L, Reis CA, Silva LF, Serpa J, et al: Metaplasia - a transdifferentiation process that facilitates cancer development: the model of gastric intestinal metaplasia. Crit Rev Oncog 2006; 12: 3-26.
24. Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M: Atrophy-metaplasia-dysplasia- carcinoma sequence in the stomach: a reality or merely an hypothesis. Best Pract Res Clin Gastroenterol 2001; 15: 983-998.
25. Shiotani A, Haruma K, Uedo N, Iishi H, Ishihara R, Tatsuta M, et al: Histological risk markers for non-cardia early gastric cancer: pattern of mucin expression and gastric cancer. Virchows Arch 2006; 449: 652-659.
26. Shiotani A, Iishi H, Uedo N, Ishiguro S, Tatsuta M, Nakae Y, et al: Evidence that loss of sonic hedgehog is an indicator of Helicobacter pylori -induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol 2005; 100: 581-587.
27. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194.
28. Take S, Mizuno M, Ishiki K, Nagahara Y, Yoshida T, Yokota K, Oguma K: Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases. J Gastroenterol 2007; 42(suppl 17):21-27.
29. Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, Enomoto S, Inoue I, Iguchi M, Maekita T, Ueda K, Utsunomiya H, Tamai H, Fujishiro M, Iwane M, Takeshita T, Mohara O, Ichinose M: Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009; 125: 2697-2703.
30. Gutierrez O, Melo M, Segura AM, Angel A, Genta RM, Graham DY: Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol 1997; 32: 664-668.
31. Shiotani A, Haruma K, Graham DY: Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol 2014; 20: 11552-11559.
32. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008; 372: 392-397.
33. Choi J, Kim SG, Yoon H, Im JP, Kim JS, Kim WH, Jung HC: Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma. Clin Gastroenterol Hepatol 2014; 12: 793-800.
34. Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T: Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012; 75: 39-46.
35. Shiotani A, Uedo N, Iishi H, Yoshiyuki Y, Ishii M, Manabe N, Kamada T, Kusunoki H, Hata J, Haruma K: Predictive factors for metachronous gastric cancer in high-risk patients after successful Helicobacter pylori eradication. Digestion 2008; 78: 113-119.